Market Overview - The three major A-share indices collectively retreated, with the Shanghai Composite Index showing resilience due to the banking and brokerage sectors, while the Shenzhen Component Index experienced fluctuations without clear rebound momentum. The ChiNext Index was notably affected by adjustments in technology growth stocks [4]. Market Performance - A total of 1,616 stocks rose, while 375 stocks fell, indicating a market with more declines than gains and significant structural differentiation [5]. - Consumer-related sectors such as film and television, retail, and tourism hotels saw a surge in stock prices, while low-valuation, high-dividend stocks like banks, liquor, and pharmaceuticals demonstrated defensive performance, with some even reaching new highs. In contrast, previously popular sectors like precious metals, photovoltaics, and semiconductors underwent significant adjustments [6]. Trading Volume - The total trading volume of the two markets was 1.8 trillion yuan, down 12.29%, reflecting a contraction in trading activity as pre-holiday risk aversion and cautious sentiment increased. Funds shifted from growth to value sectors, with defensive sectors becoming a "safe haven" for capital, leading to lower trading activity in these areas [7]. Fund Flows - There was a net outflow of 36.672 billion yuan from institutional funds, while retail investors saw a net inflow [8]. - Institutions adjusted their portfolios defensively, favoring sectors such as cultural media, food and beverage, banking, beauty care, and commercial retail, while reducing holdings in power equipment, non-ferrous metals, electronics, computing hardware, and new energy vehicles. Retail investors aligned with institutional preferences, showing a preference for defensive sectors like consumer goods and pharmaceuticals, while avoiding high-volatility sectors like new energy and semiconductors [9]. Investor Sentiment - The sentiment among retail investors was reported at 75.85%, indicating a relatively optimistic outlook [10]. - The average position of investors showed that 54.94% were fully invested, with 30.57% increasing their positions and 14.49% reducing them [14][21].

Core Viewpoint - The article discusses the "Spring Festival Effect" in the A-share market, emphasizing that it is not merely about price increases or decreases, but rather about market rhythm and style shifts during this period [3][4]. Group 1: Market Trends - Historical data from 2015 to 2025 indicates that the A-share market exhibits systematic and quantifiable characteristics around the Spring Festival, particularly in overall trends and style rotations [5]. - Pre-festival, market sentiment is generally stable, with the average increase of the Shanghai Composite Index and CSI 300 Index being approximately 0.62% and 0.77% respectively in the last five trading days before the festival, and an upward probability of about 63.6% [6][11]. - Post-festival, the market often enters a sustained upward phase, with the average increase of major indices turning positive within the first ten trading days after the festival, showing an upward probability of 72.7% for the Shanghai Composite Index and 81.8% for the CSI 1000 Index [11][12]. Group 2: Style Rotation - There is a clear rotation in market style before and after the Spring Festival. Before the festival, larger-cap stocks tend to outperform due to lower trading activity and higher certainty in earnings, as indicated by the better performance of the CSI 300 Index compared to the CSI 1000 Index [13][15]. - After the festival, the market sees a significant reversal in style, with the CSI 1000 Index showing an average increase of 2.47% in the first five trading days post-festival, outperforming the CSI 300 Index, which only saw a marginal increase of 0.01% [15][16]. - This shift indicates a return of funds and an increase in risk appetite, with investors favoring smaller-cap growth stocks that are more sensitive to liquidity [15][20]. Group 3: Future Market Predictions - For the 2026 Spring Festival, the report suggests a high probability of a phase of market recovery post-festival, driven by valuation levels, policy expectations, and capital inflows, although the path may be more complex than in previous years [18][19]. - The rotation logic of preferring defensive large-cap stocks before the festival and more elastic assets afterward remains relevant, with a focus on sectors that align with current policy support for technological innovation and new production capabilities [20][21]. - Key sectors to watch post-festival include artificial intelligence, high-end manufacturing, and renewable energy, which are expected to benefit from strong policy drivers and high industry growth [21][22].

资本市场，现在是冰火两重天。 买科技股的公募，最高年盈利233%，另一方面，持有老登股的基金经理们，逐渐被基民抛弃。 基金行业正在经历一轮大洗牌。本来嘛，基民的钱亏了，基金经理却还拿着高薪和奖金，管理费一分不 少，这事被吐槽很久了。 就在上个月，新规出来，一切都要改变。 文丨金融八卦女特约作者：兴华 · · · 除了医药女神，其他明星基金经理也有翻车的。 四季度，医药女神们纷纷扑街。还有基金持仓紧握老登股的基金经理，被爆出来自己偷偷买了很多科技 股赚了大钱，成了众矢之的。 业绩轮流翻车，去年的基金经理离职人数创下新高，已经达到453人。而基金经理总人数却在持续扩 大，很多年轻的基金经理，83%连上一轮牛市都没经历过。 整个基金行业，正在经历一轮大洗牌。 知名基金经理刘彦春的四季报，普遍亏损在5.8%-7.5%之间，最近五年基本上是腰斩。 尤其是基金的四季报一披露，不少医药女神都扑街了。张韡、赵蓓等管理的医药基都在四季度陷入了亏 损，把上半年的利润吐回去不少。 赵蓓管理的工银前沿医疗A第四季度跌了13.7%，年度回报17%。 张韡管理的添富创新医药A 第四季度跌了15.5%，年度回报为36%。 金笑非的鹏华医药 ...

Industry Updates - The Ministry of Finance, General Administration of Customs, and State Taxation Administration jointly announced a policy allowing residents of Hainan Free Trade Port to purchase imported goods at "zero tariffs," with a tax exemption limit of 10,000 RMB per person per year and no limit on purchase frequency [1] - The State Administration for Market Regulation is intensifying efforts to combat issues in live-streaming e-commerce, focusing on counterfeit goods and false marketing, and has initiated a special rectification campaign [1] - The Ministry of Industry and Information Technology has prioritized addressing the internal competition in the photovoltaic industry, aiming to achieve a dynamic balance between supply and demand through enhanced departmental collaboration [1] - Anhui Province has set a regional GDP growth target of 5% to 5.5% for 2026 [1] - The Internationally first and largest single-unit power compressed air energy storage compressor, developed by the Institute of Engineering Thermophysics of the Chinese Academy of Sciences and China Storage Energy (Beijing) Technology Co., has passed third-party testing with CNAS accreditation, reaching an internationally leading level [1] Company Updates - Kweichow Moutai responded to issues with the iMoutai App, stating that recent high demand and a surge in orders have led to difficulties in app loading and customer service line congestion [1] - Tesla's energy super factory has begun supplying capacity to multiple domestic and international markets [1] - Foxconn's new energy vehicle R&D center officially commenced operations on February 4 in Zhengzhou Airport, focusing on next-generation electronic and electrical architecture and smart driving technologies [1] - NewEase has announced that its 1.6T optical module products have achieved mass delivery and are in the process of continuous capacity enhancement [1] - Lei Jun announced via Weibo that the next-generation SU7 is expected to launch in April 2026, with pre-orders now open [1] - Yunding Xinyao signed an exclusive commercialization licensing agreement with Macao Teo, obtaining exclusive commercialization rights for MT1013 in China and the Asia-Pacific region (excluding Japan) [1] - Changan Automobile, in collaboration with CATL, is introducing sodium-ion batteries, planning to implement them in multiple models by 2026 [1]

Core Viewpoint - The National Market Supervision Administration emphasizes the need for fair competition and plans to conduct reviews and investigations to rectify policies that hinder a unified market and fair competition by 2025 [1] Group 1: Fair Competition Measures - A fair competition review will be organized in 2025 to address policies that obstruct market unity and fair competition [1] - The administration aims to investigate and rectify various policies that may lead to monopolistic practices, particularly in the pharmaceutical sector [1] Group 2: Antitrust Actions - The agency plans to address a series of monopolistic cases in the pharmaceutical industry, which is expected to lead to significant price reductions for involved drugs [1] - A total of 14,600 cases of unfair competition will be investigated and handled [1] Group 3: Market Regulation - There will be a comprehensive effort to mitigate "involution-style" competition, focusing on cost investigations, price checks, and guidance for key enterprises [1] - The initiative aims to effectively cool down "price wars" and "subsidy wars" in the market [1]

2026年，日本央行重启加息，是否会给全球宽松环境带来变数？科技主题是否依然能引领市场？在复杂 多变的环境下，如何进行多元资产配置，才能应对全球不确定性带来的挑战？近期，汇丰晋信基金与汇 丰投资管理携手举办了2026年全球投资展望分享会，邀请投资专家拨开市场迷雾，前瞻2026年环球市场 表现，捕捉多元资产配置机遇。 全球宏观：正处于人工智能超级周期的开端 在汇丰投资管理固定收益环球首席投资官、亚洲区首席投资官Michael Cross看来，市场正处于人工智能 超级周期的开端，也处于大宗商品超级周期的早期阶段。谈及美国市场，他表示："我们预计美元不会 出现大幅贬值。美国正经历一场巨大的投资热潮，流入美国的资金仍然有望保持强劲。" Michael Cross表示："关于人工智能，目前存在着广泛的观点，美国的劳动生产率目前为2%。一些学术 估算认为人工智能可以使生产率增长0.2%。还有一些估算认为，人工智能可以将生产率提高4.5%，这 是前所未有的。虽然我们毫不怀疑人工智能将会带来益处，但无法准确衡量其益处究竟有多大。这意味 着股票价格将会出现上涨趋势，但随着人们对人工智能益处的看法逐渐明朗，预计市场会出现一些波 ...

Market Overview - The A-share market experienced a decline today, with the ChiNext and Sci-Tech Innovation Board leading the drop, particularly in the non-ferrous metals sector which saw a significant plunge [1][5] - The Hong Kong market also faced a downturn, with the Hang Seng Index dropping over 1%, although Yum China saw its stock price surge by over 9% following the release of its financial results [3][12] Sector Performance - The non-ferrous metals sector faced a severe setback, with a drop exceeding 5% during the session. Key stocks such as Silver Industry and Hunan Gold hit their daily limit down [5][6] - Domestic metal futures experienced widespread declines, with the main contract for silver futures plummeting over 10%. Spot gold also fell by 3% to $4,809.87 per ounce [5] - The power equipment sector was among the worst performers, with a drop exceeding 3%, and several stocks, including Zhongheng Electric and Jinchen Co., hitting their daily limit down [7] - Other sectors such as coal, steel, and telecommunications also reported significant declines, while the beauty and personal care sector led the gains with an increase of over 3% [8] Notable Stock Movements - Yum China's stock price increased significantly, with a peak rise of over 9% after announcing a 7% year-on-year increase in system sales for Q4 2025, and a 3% increase in same-store sales [11][18] - A new stock, North Chip Life, debuted with a remarkable rise of over 210% during the session. The company focuses on innovative solutions for cardiovascular diseases and has several products in the pipeline [10][14] Financial Results - Yum China's Q4 2025 financial results showed a net increase of 587 new stores, with a 36% share of new franchise stores, and a 25% increase in operating profit to $187 million [18]

Group 1 - The main point of the article highlights that major funds have net sold over 1.5 billion in Zijin Mining [1] - In the early trading session, major funds saw net inflows in sectors such as food and beverage, pharmaceuticals, and film and television, while experiencing net outflows in the electric new energy, non-ferrous metals, and electronics sectors [1] - The electric new energy sector had a significant net outflow exceeding 15.3 billion [1] Group 2 - Pingtan Development reached the daily limit with a net buy of over 1.1 billion, leading the inflow rankings [1] - Companies like Zhongji Xuchuang, N Beixin-U, and Wangsu Technology also saw significant net inflows from major funds [1] - Zijin Mining faced the largest net sell-off, exceeding 1.5 billion, along with other companies like Tebian Electric, Xinyisheng, and Longi Green Energy experiencing notable net outflows [1]

Market Performance - The Hang Seng Index closed at 26,847, with a slight increase of 0.05% for the day and a year-to-date increase of 4.75% [1] - The Hang Seng Technology Index decreased by 1.84% for the day and is down 2.71% year-to-date [1] - The US stock market saw the Dow Jones increase by 0.53%, while the S&P 500 and Nasdaq fell by 0.51% and 1.51%, respectively [1] Sector Performance - In the Hong Kong market, the financial sector increased by 0.66% and is up 8.51% year-to-date, while the industrial sector decreased by 0.48% [2] - The real estate sector in Hong Kong saw a significant increase of 1.99% for the day and is up 17.13% year-to-date [2] Capital Flows - Southbound funds recorded a net inflow of 13.373 billion HKD, with Tencent, Alibaba, and Xiaomi being the top net buyers [3] - In contrast, SMIC, Hua Hong Semiconductor, and Jun Da Co. were the most sold stocks [3] US Market Trends - The US stock market experienced a sell-off in technology stocks, particularly in software and semiconductor sectors, with AMD's weak guidance leading to a 17% drop [3] - The S&P 500 software sector has seen an average decline of 25% since reaching a historical high last October [3] Company Analysis: Pfizer (PFE US) - Pfizer reported strong Q4 2025 earnings with revenue of 17.6 billion USD, slightly below the expected 18.1 billion USD, but adjusted net income exceeded expectations at 3.8 billion USD [4] - The company anticipates 2026 revenue between 59.5 billion to 62.5 billion USD, with adjusted EPS guidance of 2.80 to 3.00 USD [4] - Key upcoming milestones include data readouts for long-acting GLP-1 and Amylin projects, which are expected to drive significant valuation re-evaluation [4] Clinical Developments - Pfizer's VESPER-3 study showed a 12.3% weight loss effect at the 28-week mark for its long-acting GLP-1 candidate, with a potential 15.8% weight loss projected for a higher dose [5] - The company plans to initiate a Phase 3 study for the higher dose later this year, with detailed data expected at the ADA conference in June [5] Oncology Pipeline - Pfizer is advancing its PD-1/VEGF and ADC combination therapies, with ongoing Phase 3 trials for PF'4404 in colorectal cancer and additional trials planned for 2026 [6] - The market narrative is shifting towards pipeline execution strength, with obesity products and PF'4404 clinical progress expected to drive stock price increases [6]

2025年，组织开展公平竞争审查抽查，敦促有关政策制定机关对妨碍统一市场和公平竞争的政策措施进 行整改；查处医药领域系列垄断案件，推动涉案药品大幅降价；查办各类反不正当竞争案件1.46万件。 综合整治"内卷式"竞争，加强对重点企业的成本调查、价格检查、约谈指导，有效推动"价格战""补贴 战"及时降温。 经济观察网 据央视新闻客户端消息，国务院新闻办公室今天（5日）举行的新闻发布会上，市场监管总 局介绍，公平竞争是市场经济的基本原则，是建设全国统一大市场的客观要求。 ...